Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Efficacy Medication	2.07B	2.07B	1.90B	1.90B	1.58B
Efficacy Medication Growth	0.11%	8.65%	0.40%	20.39%	-0.67%
Functional Food	1.18B	973.17M	948.38M	860.09M	763.55M
Functional Food Growth	21.74%	2.61%	10.27%	12.64%	8.59%
Others	115.73M	108.88M	110.57M	100.09M	94.75M
Others Growth	6.30%	-1.53%	10.47%	5.63%	-4.76%
Total	3.37B	3.15B	2.96B	2.86B	2.43B
Total Growth	7.00%	6.33%	3.72%	17.39%	1.89%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan	2.92B	2.75B	2.55B	2.34B	2.00B
Taiwan Growth	6.36%	7.61%	8.90%	17.35%	-1.11%
Mainland China	209.24M	202.03M	211.34M	208.06M	196.76M
Mainland China Growth	3.57%	-4.40%	1.58%	5.74%	-1.21%
United States	59.40M	47.38M	-	114.72M	67.92M
United States Growth	25.37%	-	-	68.90%	16.97%
Indonesia	46.09M	23.25M	52.69M	44.30M	-
Indonesia Growth	98.25%	-55.88%	18.94%	-	-
Vietnam	43.49M	47.00M	54.42M	39.87M	58.10M
Vietnam Growth	-7.46%	-13.64%	36.49%	-31.38%	302.80%
Others	90.25M	82.94M	90.87M	104.75M	112.50M
Others Growth	8.81%	-8.73%	-13.25%	-6.89%	16.97%
Total	3.37B	3.15B	2.96B	2.86B	2.43B
Total Growth	7.00%	6.33%	3.72%	17.39%	1.89%

Source: S&P Global Market Intelligence.